Conjunctivitis

Conjunctivitis is the indication for 26 drugs in DrugBank. It is covered by 46 curated, structured indications.

Also known as: Pinkeye
Classified under: Eye Disease
Infections
Indicated drugs: Anthoxanthum odoratum
Anthoxanthum odoratum pollen
Bacitracin
Betamethasone
Chlorpheniramine
Dactylis glomerata pollen
Dermatophagoides farinae
Dermatophagoides pteronyssinus
Dexamethasone
Dexchlorpheniramine
Framycetin
Gramicidin D
Hyaluronic acid
Hydrocortisone acetate
Lolium perenne pollen
Naphazoline
Ofloxacin
Phleum pratense pollen
Poa pratensis pollen
Prednisolone
Sodium borate
Sulfacetamide
Sulfamerazine
Tetracosactide
Tetryzoline
and 1 more with a free account

Resolves to

Vocabularies

MeSHM0005015ICD-10H10SNOMED CT193857008MedDRA10000695UMLSC0009763

What you can answer from here — as of October 23, 2026

26Indicated drugsWith each drug's targets and mechanism

46Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

58Clinical trialsPhase, status and sponsor resolved per trial

2Contraindicated drugsDrugs whose labels contraindicate them in this condition

242Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Conjunctivitis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.